Co-Diagnostics (CODX) 2025 Earnings: Catalysts & Risks
Investors are keeping a close eye on Co-Diagnostics as 2025 earnings unfold. This guide breaks down what to look for ...
Stock indices move on earnings, policy changes, and macro data. This intro covers the core catalysts that drive daily swings.
23,761 articlesInvestors are keeping a close eye on Co-Diagnostics as 2025 earnings unfold. This guide breaks down what to look for ...
SpaceX is set to begin trading after a record $75 billion IPO, signaling strong appetite for space-enabled growth. Ma...
Apple stock just dropped as memory costs surge and device pricing shifts bite into margins. Traders weigh supply-chai...
Coherent is set to join the S&P 500 on March 23, 2026, triggering automatic purchases by index funds. The move follow...
Broadcom has surged after April began, but the big question remains: is the rally sustainable? This guide breaks down...
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
SpaceX kicked off its long-awaited IPO with shares trading above $150 and a valuation topping $2 trillion. This repor...
CVS Health is leveraging its vast network to tap into the GLP-1 weight-loss wave. This explainers-backed piece breaks...
Intercontinental Exchange sits at the heart of global markets, combining exchanges, data, and clearing. This piece ex...
Pfizer faced big headwinds after its Covid-era peak, but a longer horizon could open doors for outsized returns. Here...
A 68-year-old retiree taps a charitable remainder trust strategy to divest a $2.4 million concentrated stock position...
SpaceX hits the public markets with a high-profile IPO, but the spacex president warning investors message underscore...